Medical Care
Global CD147 Antibody Market Research Report 2025
- May 12, 25
- ID: 236067
- Pages: 99
- Figures: 107
- Views: 4
The global market for CD147 Antibody was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for CD147 Antibody is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for CD147 Antibody is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of CD147 Antibody include BosterBio, Bioss, BD Biosciences, GeneTex, RayBiotech, Bio-Rad, NSJ Bioreagents, BioLegend, Abcam, Cell Sciences, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for CD147 Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CD147 Antibody.
The CD147 Antibody market size, estimations, and forecasts are provided in terms of sales volume (ml) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global CD147 Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CD147 Antibody manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
BosterBio
Bioss
BD Biosciences
GeneTex
RayBiotech
Bio-Rad
NSJ Bioreagents
BioLegend
Abcam
Cell Sciences
LifeSpan BioSciences
Bethyl Laboratories
HUABIO
Thermo Fisher Scientific
Novus Biologicals
Elabscience Biotechnology
R&D Systems
Miltenyi Biotec
Biobyt
Jingjie PTM BioLab
Segment by Type
Monoclonal
Polyclonal
Segment by Application
Immunochemistry (IHC)
Immunofluorescence (IF)
Immunoprecipitation (IP)
Western Blot (WB)
ELISA
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of CD147 Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of CD147 Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
North American market for CD147 Antibody is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for CD147 Antibody is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of CD147 Antibody include BosterBio, Bioss, BD Biosciences, GeneTex, RayBiotech, Bio-Rad, NSJ Bioreagents, BioLegend, Abcam, Cell Sciences, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for CD147 Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CD147 Antibody.
The CD147 Antibody market size, estimations, and forecasts are provided in terms of sales volume (ml) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global CD147 Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CD147 Antibody manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
BosterBio
Bioss
BD Biosciences
GeneTex
RayBiotech
Bio-Rad
NSJ Bioreagents
BioLegend
Abcam
Cell Sciences
LifeSpan BioSciences
Bethyl Laboratories
HUABIO
Thermo Fisher Scientific
Novus Biologicals
Elabscience Biotechnology
R&D Systems
Miltenyi Biotec
Biobyt
Jingjie PTM BioLab
Segment by Type
Monoclonal
Polyclonal
Segment by Application
Immunochemistry (IHC)
Immunofluorescence (IF)
Immunoprecipitation (IP)
Western Blot (WB)
ELISA
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of CD147 Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of CD147 Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 CD147 Antibody Market Overview
1.1 Product Definition
1.2 CD147 Antibody by Type
1.2.1 Global CD147 Antibody Market Value Comparison by Type (2024 VS 2031)
1.2.2 Monoclonal
1.2.3 Polyclonal
1.3 CD147 Antibody by Application
1.3.1 Global CD147 Antibody Market Value by Application (2024 VS 2031)
1.3.2 Immunochemistry (IHC)
1.3.3 Immunofluorescence (IF)
1.3.4 Immunoprecipitation (IP)
1.3.5 Western Blot (WB)
1.3.6 ELISA
1.3.7 Others
1.4 Global CD147 Antibody Market Size Estimates and Forecasts
1.4.1 Global CD147 Antibody Revenue 2020-2031
1.4.2 Global CD147 Antibody Sales 2020-2031
1.4.3 Global CD147 Antibody Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 CD147 Antibody Market Competition by Manufacturers
2.1 Global CD147 Antibody Sales Market Share by Manufacturers (2020-2025)
2.2 Global CD147 Antibody Revenue Market Share by Manufacturers (2020-2025)
2.3 Global CD147 Antibody Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of CD147 Antibody, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of CD147 Antibody, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of CD147 Antibody, Product Type & Application
2.7 Global Key Manufacturers of CD147 Antibody, Date of Enter into This Industry
2.8 Global CD147 Antibody Market Competitive Situation and Trends
2.8.1 Global CD147 Antibody Market Concentration Rate
2.8.2 The Global 5 and 10 Largest CD147 Antibody Players Market Share by Revenue
2.8.3 Global CD147 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global CD147 Antibody Market Scenario by Region
3.1 Global CD147 Antibody Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global CD147 Antibody Sales by Region: 2020-2031
3.2.1 Global CD147 Antibody Sales by Region: 2020-2025
3.2.2 Global CD147 Antibody Sales by Region: 2026-2031
3.3 Global CD147 Antibody Revenue by Region: 2020-2031
3.3.1 Global CD147 Antibody Revenue by Region: 2020-2025
3.3.2 Global CD147 Antibody Revenue by Region: 2026-2031
3.4 North America CD147 Antibody Market Facts & Figures by Country
3.4.1 North America CD147 Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America CD147 Antibody Sales by Country (2020-2031)
3.4.3 North America CD147 Antibody Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe CD147 Antibody Market Facts & Figures by Country
3.5.1 Europe CD147 Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe CD147 Antibody Sales by Country (2020-2031)
3.5.3 Europe CD147 Antibody Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific CD147 Antibody Market Facts & Figures by Region
3.6.1 Asia Pacific CD147 Antibody Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific CD147 Antibody Sales by Region (2020-2031)
3.6.3 Asia Pacific CD147 Antibody Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America CD147 Antibody Market Facts & Figures by Country
3.7.1 Latin America CD147 Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America CD147 Antibody Sales by Country (2020-2031)
3.7.3 Latin America CD147 Antibody Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa CD147 Antibody Market Facts & Figures by Country
3.8.1 Middle East and Africa CD147 Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa CD147 Antibody Sales by Country (2020-2031)
3.8.3 Middle East and Africa CD147 Antibody Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global CD147 Antibody Sales by Type (2020-2031)
4.1.1 Global CD147 Antibody Sales by Type (2020-2025)
4.1.2 Global CD147 Antibody Sales by Type (2026-2031)
4.1.3 Global CD147 Antibody Sales Market Share by Type (2020-2031)
4.2 Global CD147 Antibody Revenue by Type (2020-2031)
4.2.1 Global CD147 Antibody Revenue by Type (2020-2025)
4.2.2 Global CD147 Antibody Revenue by Type (2026-2031)
4.2.3 Global CD147 Antibody Revenue Market Share by Type (2020-2031)
4.3 Global CD147 Antibody Price by Type (2020-2031)
5 Segment by Application
5.1 Global CD147 Antibody Sales by Application (2020-2031)
5.1.1 Global CD147 Antibody Sales by Application (2020-2025)
5.1.2 Global CD147 Antibody Sales by Application (2026-2031)
5.1.3 Global CD147 Antibody Sales Market Share by Application (2020-2031)
5.2 Global CD147 Antibody Revenue by Application (2020-2031)
5.2.1 Global CD147 Antibody Revenue by Application (2020-2025)
5.2.2 Global CD147 Antibody Revenue by Application (2026-2031)
5.2.3 Global CD147 Antibody Revenue Market Share by Application (2020-2031)
5.3 Global CD147 Antibody Price by Application (2020-2031)
6 Key Companies Profiled
6.1 BosterBio
6.1.1 BosterBio Company Information
6.1.2 BosterBio Description and Business Overview
6.1.3 BosterBio CD147 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.1.4 BosterBio CD147 Antibody Product Portfolio
6.1.5 BosterBio Recent Developments/Updates
6.2 Bioss
6.2.1 Bioss Company Information
6.2.2 Bioss Description and Business Overview
6.2.3 Bioss CD147 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Bioss CD147 Antibody Product Portfolio
6.2.5 Bioss Recent Developments/Updates
6.3 BD Biosciences
6.3.1 BD Biosciences Company Information
6.3.2 BD Biosciences Description and Business Overview
6.3.3 BD Biosciences CD147 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.3.4 BD Biosciences CD147 Antibody Product Portfolio
6.3.5 BD Biosciences Recent Developments/Updates
6.4 GeneTex
6.4.1 GeneTex Company Information
6.4.2 GeneTex Description and Business Overview
6.4.3 GeneTex CD147 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.4.4 GeneTex CD147 Antibody Product Portfolio
6.4.5 GeneTex Recent Developments/Updates
6.5 RayBiotech
6.5.1 RayBiotech Company Information
6.5.2 RayBiotech Description and Business Overview
6.5.3 RayBiotech CD147 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.5.4 RayBiotech CD147 Antibody Product Portfolio
6.5.5 RayBiotech Recent Developments/Updates
6.6 Bio-Rad
6.6.1 Bio-Rad Company Information
6.6.2 Bio-Rad Description and Business Overview
6.6.3 Bio-Rad CD147 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Bio-Rad CD147 Antibody Product Portfolio
6.6.5 Bio-Rad Recent Developments/Updates
6.7 NSJ Bioreagents
6.7.1 NSJ Bioreagents Company Information
6.7.2 NSJ Bioreagents Description and Business Overview
6.7.3 NSJ Bioreagents CD147 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.7.4 NSJ Bioreagents CD147 Antibody Product Portfolio
6.7.5 NSJ Bioreagents Recent Developments/Updates
6.8 BioLegend
6.8.1 BioLegend Company Information
6.8.2 BioLegend Description and Business Overview
6.8.3 BioLegend CD147 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.8.4 BioLegend CD147 Antibody Product Portfolio
6.8.5 BioLegend Recent Developments/Updates
6.9 Abcam
6.9.1 Abcam Company Information
6.9.2 Abcam Description and Business Overview
6.9.3 Abcam CD147 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Abcam CD147 Antibody Product Portfolio
6.9.5 Abcam Recent Developments/Updates
6.10 Cell Sciences
6.10.1 Cell Sciences Company Information
6.10.2 Cell Sciences Description and Business Overview
6.10.3 Cell Sciences CD147 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Cell Sciences CD147 Antibody Product Portfolio
6.10.5 Cell Sciences Recent Developments/Updates
6.11 LifeSpan BioSciences
6.11.1 LifeSpan BioSciences Company Information
6.11.2 LifeSpan BioSciences Description and Business Overview
6.11.3 LifeSpan BioSciences CD147 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.11.4 LifeSpan BioSciences CD147 Antibody Product Portfolio
6.11.5 LifeSpan BioSciences Recent Developments/Updates
6.12 Bethyl Laboratories
6.12.1 Bethyl Laboratories Company Information
6.12.2 Bethyl Laboratories Description and Business Overview
6.12.3 Bethyl Laboratories CD147 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Bethyl Laboratories CD147 Antibody Product Portfolio
6.12.5 Bethyl Laboratories Recent Developments/Updates
6.13 HUABIO
6.13.1 HUABIO Company Information
6.13.2 HUABIO Description and Business Overview
6.13.3 HUABIO CD147 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.13.4 HUABIO CD147 Antibody Product Portfolio
6.13.5 HUABIO Recent Developments/Updates
6.14 Thermo Fisher Scientific
6.14.1 Thermo Fisher Scientific Company Information
6.14.2 Thermo Fisher Scientific Description and Business Overview
6.14.3 Thermo Fisher Scientific CD147 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Thermo Fisher Scientific CD147 Antibody Product Portfolio
6.14.5 Thermo Fisher Scientific Recent Developments/Updates
6.15 Novus Biologicals
6.15.1 Novus Biologicals Company Information
6.15.2 Novus Biologicals Description and Business Overview
6.15.3 Novus Biologicals CD147 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Novus Biologicals CD147 Antibody Product Portfolio
6.15.5 Novus Biologicals Recent Developments/Updates
6.16 Elabscience Biotechnology
6.16.1 Elabscience Biotechnology Company Information
6.16.2 Elabscience Biotechnology Description and Business Overview
6.16.3 Elabscience Biotechnology CD147 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Elabscience Biotechnology CD147 Antibody Product Portfolio
6.16.5 Elabscience Biotechnology Recent Developments/Updates
6.17 R&D Systems
6.17.1 R&D Systems Company Information
6.17.2 R&D Systems Description and Business Overview
6.17.3 R&D Systems CD147 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.17.4 R&D Systems CD147 Antibody Product Portfolio
6.17.5 R&D Systems Recent Developments/Updates
6.18 Miltenyi Biotec
6.18.1 Miltenyi Biotec Company Information
6.18.2 Miltenyi Biotec Description and Business Overview
6.18.3 Miltenyi Biotec CD147 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Miltenyi Biotec CD147 Antibody Product Portfolio
6.18.5 Miltenyi Biotec Recent Developments/Updates
6.19 Biobyt
6.19.1 Biobyt Company Information
6.19.2 Biobyt Description and Business Overview
6.19.3 Biobyt CD147 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Biobyt CD147 Antibody Product Portfolio
6.19.5 Biobyt Recent Developments/Updates
6.20 Jingjie PTM BioLab
6.20.1 Jingjie PTM BioLab Company Information
6.20.2 Jingjie PTM BioLab Description and Business Overview
6.20.3 Jingjie PTM BioLab CD147 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Jingjie PTM BioLab CD147 Antibody Product Portfolio
6.20.5 Jingjie PTM BioLab Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 CD147 Antibody Industry Chain Analysis
7.2 CD147 Antibody Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 CD147 Antibody Production Mode & Process Analysis
7.4 CD147 Antibody Sales and Marketing
7.4.1 CD147 Antibody Sales Channels
7.4.2 CD147 Antibody Distributors
7.5 CD147 Antibody Customer Analysis
8 CD147 Antibody Market Dynamics
8.1 CD147 Antibody Industry Trends
8.2 CD147 Antibody Market Drivers
8.3 CD147 Antibody Market Challenges
8.4 CD147 Antibody Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 CD147 Antibody by Type
1.2.1 Global CD147 Antibody Market Value Comparison by Type (2024 VS 2031)
1.2.2 Monoclonal
1.2.3 Polyclonal
1.3 CD147 Antibody by Application
1.3.1 Global CD147 Antibody Market Value by Application (2024 VS 2031)
1.3.2 Immunochemistry (IHC)
1.3.3 Immunofluorescence (IF)
1.3.4 Immunoprecipitation (IP)
1.3.5 Western Blot (WB)
1.3.6 ELISA
1.3.7 Others
1.4 Global CD147 Antibody Market Size Estimates and Forecasts
1.4.1 Global CD147 Antibody Revenue 2020-2031
1.4.2 Global CD147 Antibody Sales 2020-2031
1.4.3 Global CD147 Antibody Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 CD147 Antibody Market Competition by Manufacturers
2.1 Global CD147 Antibody Sales Market Share by Manufacturers (2020-2025)
2.2 Global CD147 Antibody Revenue Market Share by Manufacturers (2020-2025)
2.3 Global CD147 Antibody Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of CD147 Antibody, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of CD147 Antibody, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of CD147 Antibody, Product Type & Application
2.7 Global Key Manufacturers of CD147 Antibody, Date of Enter into This Industry
2.8 Global CD147 Antibody Market Competitive Situation and Trends
2.8.1 Global CD147 Antibody Market Concentration Rate
2.8.2 The Global 5 and 10 Largest CD147 Antibody Players Market Share by Revenue
2.8.3 Global CD147 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global CD147 Antibody Market Scenario by Region
3.1 Global CD147 Antibody Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global CD147 Antibody Sales by Region: 2020-2031
3.2.1 Global CD147 Antibody Sales by Region: 2020-2025
3.2.2 Global CD147 Antibody Sales by Region: 2026-2031
3.3 Global CD147 Antibody Revenue by Region: 2020-2031
3.3.1 Global CD147 Antibody Revenue by Region: 2020-2025
3.3.2 Global CD147 Antibody Revenue by Region: 2026-2031
3.4 North America CD147 Antibody Market Facts & Figures by Country
3.4.1 North America CD147 Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America CD147 Antibody Sales by Country (2020-2031)
3.4.3 North America CD147 Antibody Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe CD147 Antibody Market Facts & Figures by Country
3.5.1 Europe CD147 Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe CD147 Antibody Sales by Country (2020-2031)
3.5.3 Europe CD147 Antibody Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific CD147 Antibody Market Facts & Figures by Region
3.6.1 Asia Pacific CD147 Antibody Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific CD147 Antibody Sales by Region (2020-2031)
3.6.3 Asia Pacific CD147 Antibody Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America CD147 Antibody Market Facts & Figures by Country
3.7.1 Latin America CD147 Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America CD147 Antibody Sales by Country (2020-2031)
3.7.3 Latin America CD147 Antibody Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa CD147 Antibody Market Facts & Figures by Country
3.8.1 Middle East and Africa CD147 Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa CD147 Antibody Sales by Country (2020-2031)
3.8.3 Middle East and Africa CD147 Antibody Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global CD147 Antibody Sales by Type (2020-2031)
4.1.1 Global CD147 Antibody Sales by Type (2020-2025)
4.1.2 Global CD147 Antibody Sales by Type (2026-2031)
4.1.3 Global CD147 Antibody Sales Market Share by Type (2020-2031)
4.2 Global CD147 Antibody Revenue by Type (2020-2031)
4.2.1 Global CD147 Antibody Revenue by Type (2020-2025)
4.2.2 Global CD147 Antibody Revenue by Type (2026-2031)
4.2.3 Global CD147 Antibody Revenue Market Share by Type (2020-2031)
4.3 Global CD147 Antibody Price by Type (2020-2031)
5 Segment by Application
5.1 Global CD147 Antibody Sales by Application (2020-2031)
5.1.1 Global CD147 Antibody Sales by Application (2020-2025)
5.1.2 Global CD147 Antibody Sales by Application (2026-2031)
5.1.3 Global CD147 Antibody Sales Market Share by Application (2020-2031)
5.2 Global CD147 Antibody Revenue by Application (2020-2031)
5.2.1 Global CD147 Antibody Revenue by Application (2020-2025)
5.2.2 Global CD147 Antibody Revenue by Application (2026-2031)
5.2.3 Global CD147 Antibody Revenue Market Share by Application (2020-2031)
5.3 Global CD147 Antibody Price by Application (2020-2031)
6 Key Companies Profiled
6.1 BosterBio
6.1.1 BosterBio Company Information
6.1.2 BosterBio Description and Business Overview
6.1.3 BosterBio CD147 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.1.4 BosterBio CD147 Antibody Product Portfolio
6.1.5 BosterBio Recent Developments/Updates
6.2 Bioss
6.2.1 Bioss Company Information
6.2.2 Bioss Description and Business Overview
6.2.3 Bioss CD147 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Bioss CD147 Antibody Product Portfolio
6.2.5 Bioss Recent Developments/Updates
6.3 BD Biosciences
6.3.1 BD Biosciences Company Information
6.3.2 BD Biosciences Description and Business Overview
6.3.3 BD Biosciences CD147 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.3.4 BD Biosciences CD147 Antibody Product Portfolio
6.3.5 BD Biosciences Recent Developments/Updates
6.4 GeneTex
6.4.1 GeneTex Company Information
6.4.2 GeneTex Description and Business Overview
6.4.3 GeneTex CD147 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.4.4 GeneTex CD147 Antibody Product Portfolio
6.4.5 GeneTex Recent Developments/Updates
6.5 RayBiotech
6.5.1 RayBiotech Company Information
6.5.2 RayBiotech Description and Business Overview
6.5.3 RayBiotech CD147 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.5.4 RayBiotech CD147 Antibody Product Portfolio
6.5.5 RayBiotech Recent Developments/Updates
6.6 Bio-Rad
6.6.1 Bio-Rad Company Information
6.6.2 Bio-Rad Description and Business Overview
6.6.3 Bio-Rad CD147 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Bio-Rad CD147 Antibody Product Portfolio
6.6.5 Bio-Rad Recent Developments/Updates
6.7 NSJ Bioreagents
6.7.1 NSJ Bioreagents Company Information
6.7.2 NSJ Bioreagents Description and Business Overview
6.7.3 NSJ Bioreagents CD147 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.7.4 NSJ Bioreagents CD147 Antibody Product Portfolio
6.7.5 NSJ Bioreagents Recent Developments/Updates
6.8 BioLegend
6.8.1 BioLegend Company Information
6.8.2 BioLegend Description and Business Overview
6.8.3 BioLegend CD147 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.8.4 BioLegend CD147 Antibody Product Portfolio
6.8.5 BioLegend Recent Developments/Updates
6.9 Abcam
6.9.1 Abcam Company Information
6.9.2 Abcam Description and Business Overview
6.9.3 Abcam CD147 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Abcam CD147 Antibody Product Portfolio
6.9.5 Abcam Recent Developments/Updates
6.10 Cell Sciences
6.10.1 Cell Sciences Company Information
6.10.2 Cell Sciences Description and Business Overview
6.10.3 Cell Sciences CD147 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Cell Sciences CD147 Antibody Product Portfolio
6.10.5 Cell Sciences Recent Developments/Updates
6.11 LifeSpan BioSciences
6.11.1 LifeSpan BioSciences Company Information
6.11.2 LifeSpan BioSciences Description and Business Overview
6.11.3 LifeSpan BioSciences CD147 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.11.4 LifeSpan BioSciences CD147 Antibody Product Portfolio
6.11.5 LifeSpan BioSciences Recent Developments/Updates
6.12 Bethyl Laboratories
6.12.1 Bethyl Laboratories Company Information
6.12.2 Bethyl Laboratories Description and Business Overview
6.12.3 Bethyl Laboratories CD147 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Bethyl Laboratories CD147 Antibody Product Portfolio
6.12.5 Bethyl Laboratories Recent Developments/Updates
6.13 HUABIO
6.13.1 HUABIO Company Information
6.13.2 HUABIO Description and Business Overview
6.13.3 HUABIO CD147 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.13.4 HUABIO CD147 Antibody Product Portfolio
6.13.5 HUABIO Recent Developments/Updates
6.14 Thermo Fisher Scientific
6.14.1 Thermo Fisher Scientific Company Information
6.14.2 Thermo Fisher Scientific Description and Business Overview
6.14.3 Thermo Fisher Scientific CD147 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Thermo Fisher Scientific CD147 Antibody Product Portfolio
6.14.5 Thermo Fisher Scientific Recent Developments/Updates
6.15 Novus Biologicals
6.15.1 Novus Biologicals Company Information
6.15.2 Novus Biologicals Description and Business Overview
6.15.3 Novus Biologicals CD147 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Novus Biologicals CD147 Antibody Product Portfolio
6.15.5 Novus Biologicals Recent Developments/Updates
6.16 Elabscience Biotechnology
6.16.1 Elabscience Biotechnology Company Information
6.16.2 Elabscience Biotechnology Description and Business Overview
6.16.3 Elabscience Biotechnology CD147 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Elabscience Biotechnology CD147 Antibody Product Portfolio
6.16.5 Elabscience Biotechnology Recent Developments/Updates
6.17 R&D Systems
6.17.1 R&D Systems Company Information
6.17.2 R&D Systems Description and Business Overview
6.17.3 R&D Systems CD147 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.17.4 R&D Systems CD147 Antibody Product Portfolio
6.17.5 R&D Systems Recent Developments/Updates
6.18 Miltenyi Biotec
6.18.1 Miltenyi Biotec Company Information
6.18.2 Miltenyi Biotec Description and Business Overview
6.18.3 Miltenyi Biotec CD147 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Miltenyi Biotec CD147 Antibody Product Portfolio
6.18.5 Miltenyi Biotec Recent Developments/Updates
6.19 Biobyt
6.19.1 Biobyt Company Information
6.19.2 Biobyt Description and Business Overview
6.19.3 Biobyt CD147 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Biobyt CD147 Antibody Product Portfolio
6.19.5 Biobyt Recent Developments/Updates
6.20 Jingjie PTM BioLab
6.20.1 Jingjie PTM BioLab Company Information
6.20.2 Jingjie PTM BioLab Description and Business Overview
6.20.3 Jingjie PTM BioLab CD147 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Jingjie PTM BioLab CD147 Antibody Product Portfolio
6.20.5 Jingjie PTM BioLab Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 CD147 Antibody Industry Chain Analysis
7.2 CD147 Antibody Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 CD147 Antibody Production Mode & Process Analysis
7.4 CD147 Antibody Sales and Marketing
7.4.1 CD147 Antibody Sales Channels
7.4.2 CD147 Antibody Distributors
7.5 CD147 Antibody Customer Analysis
8 CD147 Antibody Market Dynamics
8.1 CD147 Antibody Industry Trends
8.2 CD147 Antibody Market Drivers
8.3 CD147 Antibody Market Challenges
8.4 CD147 Antibody Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global CD147 Antibody Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global CD147 Antibody Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global CD147 Antibody Market Competitive Situation by Manufacturers in 2024
Table 4. Global CD147 Antibody Sales (ml) of Key Manufacturers (2020-2025)
Table 5. Global CD147 Antibody Sales Market Share by Manufacturers (2020-2025)
Table 6. Global CD147 Antibody Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global CD147 Antibody Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market CD147 Antibody Average Price (US$/ml) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of CD147 Antibody, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of CD147 Antibody, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of CD147 Antibody, Product Type & Application
Table 12. Global Key Manufacturers of CD147 Antibody, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global CD147 Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CD147 Antibody as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global CD147 Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global CD147 Antibody Sales by Region (2020-2025) & (ml)
Table 18. Global CD147 Antibody Sales Market Share by Region (2020-2025)
Table 19. Global CD147 Antibody Sales by Region (2026-2031) & (ml)
Table 20. Global CD147 Antibody Sales Market Share by Region (2026-2031)
Table 21. Global CD147 Antibody Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global CD147 Antibody Revenue Market Share by Region (2020-2025)
Table 23. Global CD147 Antibody Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global CD147 Antibody Revenue Market Share by Region (2026-2031)
Table 25. North America CD147 Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America CD147 Antibody Sales by Country (2020-2025) & (ml)
Table 27. North America CD147 Antibody Sales by Country (2026-2031) & (ml)
Table 28. North America CD147 Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America CD147 Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe CD147 Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe CD147 Antibody Sales by Country (2020-2025) & (ml)
Table 32. Europe CD147 Antibody Sales by Country (2026-2031) & (ml)
Table 33. Europe CD147 Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe CD147 Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific CD147 Antibody Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific CD147 Antibody Sales by Region (2020-2025) & (ml)
Table 37. Asia Pacific CD147 Antibody Sales by Region (2026-2031) & (ml)
Table 38. Asia Pacific CD147 Antibody Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific CD147 Antibody Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America CD147 Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America CD147 Antibody Sales by Country (2020-2025) & (ml)
Table 42. Latin America CD147 Antibody Sales by Country (2026-2031) & (ml)
Table 43. Latin America CD147 Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America CD147 Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa CD147 Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa CD147 Antibody Sales by Country (2020-2025) & (ml)
Table 47. Middle East and Africa CD147 Antibody Sales by Country (2026-2031) & (ml)
Table 48. Middle East and Africa CD147 Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa CD147 Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global CD147 Antibody Sales (ml) by Type (2020-2025)
Table 51. Global CD147 Antibody Sales (ml) by Type (2026-2031)
Table 52. Global CD147 Antibody Sales Market Share by Type (2020-2025)
Table 53. Global CD147 Antibody Sales Market Share by Type (2026-2031)
Table 54. Global CD147 Antibody Revenue (US$ Million) by Type (2020-2025)
Table 55. Global CD147 Antibody Revenue (US$ Million) by Type (2026-2031)
Table 56. Global CD147 Antibody Revenue Market Share by Type (2020-2025)
Table 57. Global CD147 Antibody Revenue Market Share by Type (2026-2031)
Table 58. Global CD147 Antibody Price (US$/ml) by Type (2020-2025)
Table 59. Global CD147 Antibody Price (US$/ml) by Type (2026-2031)
Table 60. Global CD147 Antibody Sales (ml) by Application (2020-2025)
Table 61. Global CD147 Antibody Sales (ml) by Application (2026-2031)
Table 62. Global CD147 Antibody Sales Market Share by Application (2020-2025)
Table 63. Global CD147 Antibody Sales Market Share by Application (2026-2031)
Table 64. Global CD147 Antibody Revenue (US$ Million) by Application (2020-2025)
Table 65. Global CD147 Antibody Revenue (US$ Million) by Application (2026-2031)
Table 66. Global CD147 Antibody Revenue Market Share by Application (2020-2025)
Table 67. Global CD147 Antibody Revenue Market Share by Application (2026-2031)
Table 68. Global CD147 Antibody Price (US$/ml) by Application (2020-2025)
Table 69. Global CD147 Antibody Price (US$/ml) by Application (2026-2031)
Table 70. BosterBio Company Information
Table 71. BosterBio Description and Business Overview
Table 72. BosterBio CD147 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 73. BosterBio CD147 Antibody Product
Table 74. BosterBio Recent Developments/Updates
Table 75. Bioss Company Information
Table 76. Bioss Description and Business Overview
Table 77. Bioss CD147 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 78. Bioss CD147 Antibody Product
Table 79. Bioss Recent Developments/Updates
Table 80. BD Biosciences Company Information
Table 81. BD Biosciences Description and Business Overview
Table 82. BD Biosciences CD147 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 83. BD Biosciences CD147 Antibody Product
Table 84. BD Biosciences Recent Developments/Updates
Table 85. GeneTex Company Information
Table 86. GeneTex Description and Business Overview
Table 87. GeneTex CD147 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 88. GeneTex CD147 Antibody Product
Table 89. GeneTex Recent Developments/Updates
Table 90. RayBiotech Company Information
Table 91. RayBiotech Description and Business Overview
Table 92. RayBiotech CD147 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 93. RayBiotech CD147 Antibody Product
Table 94. RayBiotech Recent Developments/Updates
Table 95. Bio-Rad Company Information
Table 96. Bio-Rad Description and Business Overview
Table 97. Bio-Rad CD147 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 98. Bio-Rad CD147 Antibody Product
Table 99. Bio-Rad Recent Developments/Updates
Table 100. NSJ Bioreagents Company Information
Table 101. NSJ Bioreagents Description and Business Overview
Table 102. NSJ Bioreagents CD147 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 103. NSJ Bioreagents CD147 Antibody Product
Table 104. NSJ Bioreagents Recent Developments/Updates
Table 105. BioLegend Company Information
Table 106. BioLegend Description and Business Overview
Table 107. BioLegend CD147 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 108. BioLegend CD147 Antibody Product
Table 109. BioLegend Recent Developments/Updates
Table 110. Abcam Company Information
Table 111. Abcam Description and Business Overview
Table 112. Abcam CD147 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 113. Abcam CD147 Antibody Product
Table 114. Abcam Recent Developments/Updates
Table 115. Cell Sciences Company Information
Table 116. Cell Sciences Description and Business Overview
Table 117. Cell Sciences CD147 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 118. Cell Sciences CD147 Antibody Product
Table 119. Cell Sciences Recent Developments/Updates
Table 120. LifeSpan BioSciences Company Information
Table 121. LifeSpan BioSciences Description and Business Overview
Table 122. LifeSpan BioSciences CD147 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 123. LifeSpan BioSciences CD147 Antibody Product
Table 124. LifeSpan BioSciences Recent Developments/Updates
Table 125. Bethyl Laboratories Company Information
Table 126. Bethyl Laboratories Description and Business Overview
Table 127. Bethyl Laboratories CD147 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 128. Bethyl Laboratories CD147 Antibody Product
Table 129. Bethyl Laboratories Recent Developments/Updates
Table 130. HUABIO Company Information
Table 131. HUABIO Description and Business Overview
Table 132. HUABIO CD147 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 133. HUABIO CD147 Antibody Product
Table 134. HUABIO Recent Developments/Updates
Table 135. Thermo Fisher Scientific Company Information
Table 136. Thermo Fisher Scientific Description and Business Overview
Table 137. Thermo Fisher Scientific CD147 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 138. Thermo Fisher Scientific CD147 Antibody Product
Table 139. Thermo Fisher Scientific Recent Developments/Updates
Table 140. Novus Biologicals Company Information
Table 141. Novus Biologicals Description and Business Overview
Table 142. Novus Biologicals CD147 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 143. Novus Biologicals CD147 Antibody Product
Table 144. Novus Biologicals Recent Developments/Updates
Table 145. Elabscience Biotechnology Company Information
Table 146. Elabscience Biotechnology Description and Business Overview
Table 147. Elabscience Biotechnology CD147 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 148. Elabscience Biotechnology CD147 Antibody Product
Table 149. Elabscience Biotechnology Recent Developments/Updates
Table 150. R&D Systems Company Information
Table 151. R&D Systems Description and Business Overview
Table 152. R&D Systems CD147 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 153. R&D Systems CD147 Antibody Product
Table 154. R&D Systems Recent Developments/Updates
Table 155. Miltenyi Biotec Company Information
Table 156. Miltenyi Biotec Description and Business Overview
Table 157. Miltenyi Biotec CD147 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 158. Miltenyi Biotec CD147 Antibody Product
Table 159. Miltenyi Biotec Recent Developments/Updates
Table 160. Biobyt Company Information
Table 161. Biobyt Description and Business Overview
Table 162. Biobyt CD147 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 163. Biobyt CD147 Antibody Product
Table 164. Biobyt Recent Developments/Updates
Table 165. Jingjie PTM BioLab Company Information
Table 166. Jingjie PTM BioLab Description and Business Overview
Table 167. Jingjie PTM BioLab CD147 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 168. Jingjie PTM BioLab CD147 Antibody Product
Table 169. Jingjie PTM BioLab Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. CD147 Antibody Distributors List
Table 173. CD147 Antibody Customers List
Table 174. CD147 Antibody Market Trends
Table 175. CD147 Antibody Market Drivers
Table 176. CD147 Antibody Market Challenges
Table 177. CD147 Antibody Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
Table 181. Authors List of This Report
List of Figures
Figure 1. Product Picture of CD147 Antibody
Figure 2. Global CD147 Antibody Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global CD147 Antibody Market Share by Type: 2024 & 2031
Figure 4. Monoclonal Product Picture
Figure 5. Polyclonal Product Picture
Figure 6. Global CD147 Antibody Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global CD147 Antibody Market Share by Application: 2024 & 2031
Figure 8. Immunochemistry (IHC)
Figure 9. Immunofluorescence (IF)
Figure 10. Immunoprecipitation (IP)
Figure 11. Western Blot (WB)
Figure 12. ELISA
Figure 13. Others
Figure 14. Global CD147 Antibody Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global CD147 Antibody Market Size (2020-2031) & (US$ Million)
Figure 16. Global CD147 Antibody Sales (2020-2031) & (ml)
Figure 17. Global CD147 Antibody Average Price (US$/ml) & (2020-2031)
Figure 18. CD147 Antibody Report Years Considered
Figure 19. CD147 Antibody Sales Share by Manufacturers in 2024
Figure 20. Global CD147 Antibody Revenue Share by Manufacturers in 2024
Figure 21. Global 5 and 10 Largest CD147 Antibody Players: Market Share by Revenue in CD147 Antibody in 2024
Figure 22. CD147 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Global CD147 Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 24. North America CD147 Antibody Sales Market Share by Country (2020-2031)
Figure 25. North America CD147 Antibody Revenue Market Share by Country (2020-2031)
Figure 26. United States CD147 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Canada CD147 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Europe CD147 Antibody Sales Market Share by Country (2020-2031)
Figure 29. Europe CD147 Antibody Revenue Market Share by Country (2020-2031)
Figure 30. Germany CD147 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. France CD147 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. U.K. CD147 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Italy CD147 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Russia CD147 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Asia Pacific CD147 Antibody Sales Market Share by Region (2020-2031)
Figure 36. Asia Pacific CD147 Antibody Revenue Market Share by Region (2020-2031)
Figure 37. China CD147 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Japan CD147 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. South Korea CD147 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. India CD147 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Australia CD147 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. China Taiwan CD147 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Southeast Asia CD147 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America CD147 Antibody Sales Market Share by Country (2020-2031)
Figure 45. Latin America CD147 Antibody Revenue Market Share by Country (2020-2031)
Figure 46. Mexico CD147 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil CD147 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina CD147 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa CD147 Antibody Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa CD147 Antibody Revenue Market Share by Country (2020-2031)
Figure 51. Turkey CD147 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia CD147 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. UAE CD147 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of CD147 Antibody by Type (2020-2031)
Figure 55. Global Revenue Market Share of CD147 Antibody by Type (2020-2031)
Figure 56. Global CD147 Antibody Price (US$/ml) by Type (2020-2031)
Figure 57. Global Sales Market Share of CD147 Antibody by Application (2020-2031)
Figure 58. Global Revenue Market Share of CD147 Antibody by Application (2020-2031)
Figure 59. Global CD147 Antibody Price (US$/ml) by Application (2020-2031)
Figure 60. CD147 Antibody Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Global CD147 Antibody Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global CD147 Antibody Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global CD147 Antibody Market Competitive Situation by Manufacturers in 2024
Table 4. Global CD147 Antibody Sales (ml) of Key Manufacturers (2020-2025)
Table 5. Global CD147 Antibody Sales Market Share by Manufacturers (2020-2025)
Table 6. Global CD147 Antibody Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global CD147 Antibody Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market CD147 Antibody Average Price (US$/ml) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of CD147 Antibody, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of CD147 Antibody, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of CD147 Antibody, Product Type & Application
Table 12. Global Key Manufacturers of CD147 Antibody, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global CD147 Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CD147 Antibody as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global CD147 Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global CD147 Antibody Sales by Region (2020-2025) & (ml)
Table 18. Global CD147 Antibody Sales Market Share by Region (2020-2025)
Table 19. Global CD147 Antibody Sales by Region (2026-2031) & (ml)
Table 20. Global CD147 Antibody Sales Market Share by Region (2026-2031)
Table 21. Global CD147 Antibody Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global CD147 Antibody Revenue Market Share by Region (2020-2025)
Table 23. Global CD147 Antibody Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global CD147 Antibody Revenue Market Share by Region (2026-2031)
Table 25. North America CD147 Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America CD147 Antibody Sales by Country (2020-2025) & (ml)
Table 27. North America CD147 Antibody Sales by Country (2026-2031) & (ml)
Table 28. North America CD147 Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America CD147 Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe CD147 Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe CD147 Antibody Sales by Country (2020-2025) & (ml)
Table 32. Europe CD147 Antibody Sales by Country (2026-2031) & (ml)
Table 33. Europe CD147 Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe CD147 Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific CD147 Antibody Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific CD147 Antibody Sales by Region (2020-2025) & (ml)
Table 37. Asia Pacific CD147 Antibody Sales by Region (2026-2031) & (ml)
Table 38. Asia Pacific CD147 Antibody Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific CD147 Antibody Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America CD147 Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America CD147 Antibody Sales by Country (2020-2025) & (ml)
Table 42. Latin America CD147 Antibody Sales by Country (2026-2031) & (ml)
Table 43. Latin America CD147 Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America CD147 Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa CD147 Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa CD147 Antibody Sales by Country (2020-2025) & (ml)
Table 47. Middle East and Africa CD147 Antibody Sales by Country (2026-2031) & (ml)
Table 48. Middle East and Africa CD147 Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa CD147 Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global CD147 Antibody Sales (ml) by Type (2020-2025)
Table 51. Global CD147 Antibody Sales (ml) by Type (2026-2031)
Table 52. Global CD147 Antibody Sales Market Share by Type (2020-2025)
Table 53. Global CD147 Antibody Sales Market Share by Type (2026-2031)
Table 54. Global CD147 Antibody Revenue (US$ Million) by Type (2020-2025)
Table 55. Global CD147 Antibody Revenue (US$ Million) by Type (2026-2031)
Table 56. Global CD147 Antibody Revenue Market Share by Type (2020-2025)
Table 57. Global CD147 Antibody Revenue Market Share by Type (2026-2031)
Table 58. Global CD147 Antibody Price (US$/ml) by Type (2020-2025)
Table 59. Global CD147 Antibody Price (US$/ml) by Type (2026-2031)
Table 60. Global CD147 Antibody Sales (ml) by Application (2020-2025)
Table 61. Global CD147 Antibody Sales (ml) by Application (2026-2031)
Table 62. Global CD147 Antibody Sales Market Share by Application (2020-2025)
Table 63. Global CD147 Antibody Sales Market Share by Application (2026-2031)
Table 64. Global CD147 Antibody Revenue (US$ Million) by Application (2020-2025)
Table 65. Global CD147 Antibody Revenue (US$ Million) by Application (2026-2031)
Table 66. Global CD147 Antibody Revenue Market Share by Application (2020-2025)
Table 67. Global CD147 Antibody Revenue Market Share by Application (2026-2031)
Table 68. Global CD147 Antibody Price (US$/ml) by Application (2020-2025)
Table 69. Global CD147 Antibody Price (US$/ml) by Application (2026-2031)
Table 70. BosterBio Company Information
Table 71. BosterBio Description and Business Overview
Table 72. BosterBio CD147 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 73. BosterBio CD147 Antibody Product
Table 74. BosterBio Recent Developments/Updates
Table 75. Bioss Company Information
Table 76. Bioss Description and Business Overview
Table 77. Bioss CD147 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 78. Bioss CD147 Antibody Product
Table 79. Bioss Recent Developments/Updates
Table 80. BD Biosciences Company Information
Table 81. BD Biosciences Description and Business Overview
Table 82. BD Biosciences CD147 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 83. BD Biosciences CD147 Antibody Product
Table 84. BD Biosciences Recent Developments/Updates
Table 85. GeneTex Company Information
Table 86. GeneTex Description and Business Overview
Table 87. GeneTex CD147 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 88. GeneTex CD147 Antibody Product
Table 89. GeneTex Recent Developments/Updates
Table 90. RayBiotech Company Information
Table 91. RayBiotech Description and Business Overview
Table 92. RayBiotech CD147 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 93. RayBiotech CD147 Antibody Product
Table 94. RayBiotech Recent Developments/Updates
Table 95. Bio-Rad Company Information
Table 96. Bio-Rad Description and Business Overview
Table 97. Bio-Rad CD147 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 98. Bio-Rad CD147 Antibody Product
Table 99. Bio-Rad Recent Developments/Updates
Table 100. NSJ Bioreagents Company Information
Table 101. NSJ Bioreagents Description and Business Overview
Table 102. NSJ Bioreagents CD147 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 103. NSJ Bioreagents CD147 Antibody Product
Table 104. NSJ Bioreagents Recent Developments/Updates
Table 105. BioLegend Company Information
Table 106. BioLegend Description and Business Overview
Table 107. BioLegend CD147 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 108. BioLegend CD147 Antibody Product
Table 109. BioLegend Recent Developments/Updates
Table 110. Abcam Company Information
Table 111. Abcam Description and Business Overview
Table 112. Abcam CD147 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 113. Abcam CD147 Antibody Product
Table 114. Abcam Recent Developments/Updates
Table 115. Cell Sciences Company Information
Table 116. Cell Sciences Description and Business Overview
Table 117. Cell Sciences CD147 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 118. Cell Sciences CD147 Antibody Product
Table 119. Cell Sciences Recent Developments/Updates
Table 120. LifeSpan BioSciences Company Information
Table 121. LifeSpan BioSciences Description and Business Overview
Table 122. LifeSpan BioSciences CD147 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 123. LifeSpan BioSciences CD147 Antibody Product
Table 124. LifeSpan BioSciences Recent Developments/Updates
Table 125. Bethyl Laboratories Company Information
Table 126. Bethyl Laboratories Description and Business Overview
Table 127. Bethyl Laboratories CD147 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 128. Bethyl Laboratories CD147 Antibody Product
Table 129. Bethyl Laboratories Recent Developments/Updates
Table 130. HUABIO Company Information
Table 131. HUABIO Description and Business Overview
Table 132. HUABIO CD147 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 133. HUABIO CD147 Antibody Product
Table 134. HUABIO Recent Developments/Updates
Table 135. Thermo Fisher Scientific Company Information
Table 136. Thermo Fisher Scientific Description and Business Overview
Table 137. Thermo Fisher Scientific CD147 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 138. Thermo Fisher Scientific CD147 Antibody Product
Table 139. Thermo Fisher Scientific Recent Developments/Updates
Table 140. Novus Biologicals Company Information
Table 141. Novus Biologicals Description and Business Overview
Table 142. Novus Biologicals CD147 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 143. Novus Biologicals CD147 Antibody Product
Table 144. Novus Biologicals Recent Developments/Updates
Table 145. Elabscience Biotechnology Company Information
Table 146. Elabscience Biotechnology Description and Business Overview
Table 147. Elabscience Biotechnology CD147 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 148. Elabscience Biotechnology CD147 Antibody Product
Table 149. Elabscience Biotechnology Recent Developments/Updates
Table 150. R&D Systems Company Information
Table 151. R&D Systems Description and Business Overview
Table 152. R&D Systems CD147 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 153. R&D Systems CD147 Antibody Product
Table 154. R&D Systems Recent Developments/Updates
Table 155. Miltenyi Biotec Company Information
Table 156. Miltenyi Biotec Description and Business Overview
Table 157. Miltenyi Biotec CD147 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 158. Miltenyi Biotec CD147 Antibody Product
Table 159. Miltenyi Biotec Recent Developments/Updates
Table 160. Biobyt Company Information
Table 161. Biobyt Description and Business Overview
Table 162. Biobyt CD147 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 163. Biobyt CD147 Antibody Product
Table 164. Biobyt Recent Developments/Updates
Table 165. Jingjie PTM BioLab Company Information
Table 166. Jingjie PTM BioLab Description and Business Overview
Table 167. Jingjie PTM BioLab CD147 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 168. Jingjie PTM BioLab CD147 Antibody Product
Table 169. Jingjie PTM BioLab Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. CD147 Antibody Distributors List
Table 173. CD147 Antibody Customers List
Table 174. CD147 Antibody Market Trends
Table 175. CD147 Antibody Market Drivers
Table 176. CD147 Antibody Market Challenges
Table 177. CD147 Antibody Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
Table 181. Authors List of This Report
List of Figures
Figure 1. Product Picture of CD147 Antibody
Figure 2. Global CD147 Antibody Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global CD147 Antibody Market Share by Type: 2024 & 2031
Figure 4. Monoclonal Product Picture
Figure 5. Polyclonal Product Picture
Figure 6. Global CD147 Antibody Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global CD147 Antibody Market Share by Application: 2024 & 2031
Figure 8. Immunochemistry (IHC)
Figure 9. Immunofluorescence (IF)
Figure 10. Immunoprecipitation (IP)
Figure 11. Western Blot (WB)
Figure 12. ELISA
Figure 13. Others
Figure 14. Global CD147 Antibody Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global CD147 Antibody Market Size (2020-2031) & (US$ Million)
Figure 16. Global CD147 Antibody Sales (2020-2031) & (ml)
Figure 17. Global CD147 Antibody Average Price (US$/ml) & (2020-2031)
Figure 18. CD147 Antibody Report Years Considered
Figure 19. CD147 Antibody Sales Share by Manufacturers in 2024
Figure 20. Global CD147 Antibody Revenue Share by Manufacturers in 2024
Figure 21. Global 5 and 10 Largest CD147 Antibody Players: Market Share by Revenue in CD147 Antibody in 2024
Figure 22. CD147 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Global CD147 Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 24. North America CD147 Antibody Sales Market Share by Country (2020-2031)
Figure 25. North America CD147 Antibody Revenue Market Share by Country (2020-2031)
Figure 26. United States CD147 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Canada CD147 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Europe CD147 Antibody Sales Market Share by Country (2020-2031)
Figure 29. Europe CD147 Antibody Revenue Market Share by Country (2020-2031)
Figure 30. Germany CD147 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. France CD147 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. U.K. CD147 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Italy CD147 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Russia CD147 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Asia Pacific CD147 Antibody Sales Market Share by Region (2020-2031)
Figure 36. Asia Pacific CD147 Antibody Revenue Market Share by Region (2020-2031)
Figure 37. China CD147 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Japan CD147 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. South Korea CD147 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. India CD147 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Australia CD147 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. China Taiwan CD147 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Southeast Asia CD147 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America CD147 Antibody Sales Market Share by Country (2020-2031)
Figure 45. Latin America CD147 Antibody Revenue Market Share by Country (2020-2031)
Figure 46. Mexico CD147 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil CD147 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina CD147 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa CD147 Antibody Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa CD147 Antibody Revenue Market Share by Country (2020-2031)
Figure 51. Turkey CD147 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia CD147 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. UAE CD147 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of CD147 Antibody by Type (2020-2031)
Figure 55. Global Revenue Market Share of CD147 Antibody by Type (2020-2031)
Figure 56. Global CD147 Antibody Price (US$/ml) by Type (2020-2031)
Figure 57. Global Sales Market Share of CD147 Antibody by Application (2020-2031)
Figure 58. Global Revenue Market Share of CD147 Antibody by Application (2020-2031)
Figure 59. Global CD147 Antibody Price (US$/ml) by Application (2020-2031)
Figure 60. CD147 Antibody Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Solar Storage System Market Research Report 2025
Jul 08, 25
Global Automotive Winches Market Research Report 2025
Jul 08, 25
Global Electronic Immobilizer Market Research Report 2025
Jul 08, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232